Part:BBa_K5477048:Design
Testing of the SUPERMOM Concept
- 10INCOMPATIBLE WITH RFC[10]Illegal XbaI site found at 1606
Illegal XbaI site found at 4766
Illegal PstI site found at 1790
Illegal PstI site found at 1961
Illegal PstI site found at 5712
Illegal PstI site found at 5909
Illegal PstI site found at 6293
Illegal PstI site found at 6733
Illegal PstI site found at 6793 - 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 182
Illegal PstI site found at 1790
Illegal PstI site found at 1961
Illegal PstI site found at 5712
Illegal PstI site found at 5909
Illegal PstI site found at 6293
Illegal PstI site found at 6733
Illegal PstI site found at 6793 - 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 1740
Illegal BglII site found at 2751
Illegal XhoI site found at 4823 - 23INCOMPATIBLE WITH RFC[23]Illegal XbaI site found at 1606
Illegal XbaI site found at 4766
Illegal PstI site found at 1790
Illegal PstI site found at 1961
Illegal PstI site found at 5712
Illegal PstI site found at 5909
Illegal PstI site found at 6293
Illegal PstI site found at 6733
Illegal PstI site found at 6793 - 25INCOMPATIBLE WITH RFC[25]Illegal XbaI site found at 1606
Illegal XbaI site found at 4766
Illegal PstI site found at 1790
Illegal PstI site found at 1961
Illegal PstI site found at 5712
Illegal PstI site found at 5909
Illegal PstI site found at 6293
Illegal PstI site found at 6733
Illegal PstI site found at 6793
Illegal NgoMIV site found at 6115
Illegal NgoMIV site found at 6234
Illegal AgeI site found at 37 - 1000COMPATIBLE WITH RFC[1000]
Design Notes
Receptor Module
pRET2-LexA-mERα(LBD) | BBa_K5477029: This receptor module includes the pRET2 promoter, driving the expression of a LexA-mERα(LBD) fusion protein. The LexA DNA-binding domain (DBD) is fused to the ligand-binding domain (LBD) of a mutant Estrogen Receptor Alpha (mERα), which is engineered to exhibit high specificity towards BPA and related compounds. Upon ligand binding, the LexA-mERα(LBD) fusion protein undergoes a conformational shift, enabling it to bind to Lex6Op sequences in the reporter and detox modules, thus initiating the transcriptional response. Reporter Module
Lex6Op-pLEU2-NanoLuc | BBa_K5477031: The reporter module contains Lex6Op operator sequences, which serve as binding sites for the activated LexA-mERα(LBD) protein. Binding of LexA to these sequences activates the pLEU2 promoter, leading to the expression of NanoLuc luciferase. NanoLuc, a highly efficient luciferase, emits bioluminescence in the presence of its substrate. The intensity of this signal correlates directly with the concentration of the ligand (BPA or similar compounds) bound to the mERα receptor, enabling real-time detection. Detoxification Module
CYP3A4-MYC-pGAL1/10-POR | BBa_K5477039: The detoxification module incorporates the cytochrome P450 enzyme CYP3A4, which plays a key role in the oxidative metabolism of various EDCs, including BPA. CYP3A4 is regulated by the pGAL1/10 bidirectional promoter and is fused with a MYC tag for detection. The co-expression of NADPH-cytochrome P450 reductase (POR), driven by the same promoter, ensures efficient electron transfer to CYP3A4, facilitating its catalytic activity. This module enables the oxidation and detoxification of BPA, converting it into more hydrophilic and excretable metabolites, reducing its harmful effects.
Source
Homo sapiens and Saccharomyces cerevisiae